HRT Financial’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

HRT Financial’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,750	Closed	-$6K	–	3342
2024 Q1	$6K	Hold	18,750	–	–	﹤0.01%	2106
2023 Q4	$3K	Sell	18,750 -400	-2%	-$84	﹤0.01%	2166
2023 Q3	$3K	Buy	19,150 +400	+2%	+$92	﹤0.01%	2227
2023 Q2	$2K	Buy	18,750 +50	+0.3%	+$4	﹤0.01%	2298
2023 Q1	$0	Buy	+18,700	New	+$1.27K	﹤0.01%	3377

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

HRT Financial's AONCW Position: Q2 2024 in Review

HRT Financial sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 18,750 shares — an estimated $6K sold.

HRT Financial first reported a position in AONCW in Q1 2023 and held it in 5 quarters. The position peaked at $6K in Q1 2024. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

HRT Financial reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
HRT Financial sold 18,750 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $6K.
HRT Financial first reported a position in American Oncology Network, Inc. Warrant in Q1 2023 and held it in 5 quarters.
HRT Financial's American Oncology Network, Inc. Warrant position peaked at $6K in Q1 2024.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.